UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of: October 2020 (Report No. 3)

 

Commission file number: 001-38094

 

FORESIGHT AUTONOMOUS HOLDINGS LTD.

(Translation of registrant’s name into English)

 

7 Golda Meir

Ness Ziona 7403650 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒        Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____ 

 

 

 

 

 

 

CONTENTS

 

Attached hereto and incorporated herein is the Registrant’s press release issued on October 21, 2020, titled “Foresight to Launch Its COVID-19 Symptom Detection Solution in Japan at SEECAT 2020 Exhibition.”

 

The first two paragraphs and the section titled “Forward-Looking Statements” in the press release are incorporated by reference into the Registrant’s Registration Statements on Form F-3 (File No. 333-229715) and Form S-8 (Registration No. 333-229716 and 333-239474) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

Exhibit No.   Description
     
99.1   Press release issued by Foresight Autonomous Holdings Ltd. on October 21, 2020, titled “Foresight to Launch Its COVID-19 Symptom Detection Solution in Japan at SEECAT 2020 Exhibition.”

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Foresight Autonomous Holdings Ltd.
  (Registrant)
     
Date: October 21, 2020 By: /s/ Eli Yoresh
  Name:   Eli Yoresh
  Title: Chief Financial Officer

 

 

2

 

 

Exhibit 99.1

 

 

Foresight to Launch Its COVID-19 Symptom Detection Solution in Japan at SEECAT 2020 Exhibition

 

The solution will be presented by a leading Japanese trading house, which distributes

various products to both governmental and commercial channels

 

Ness Ziona, Israel – October 21, 2020 - Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), an innovator in automotive vision, will launch its COVID-19 symptom detection mass screening solution at SEECAT 2020 exhibition, October 21-23, 2020 in Tokyo, Japan. The solution will be presented by a leading Japanese trading house focusing on communication and security solutions, which has worked with various Israeli technology companies for more than 25 years, providing solutions to protect critical facilities such as borders, airports, and nuclear reactors.

 

The Japanese trading house will present Foresight’s solution, designed to rapidly and accurately detect some of the main symptoms associated with the COVID-19 virus. The first generation of the solution, comprised of a thermal and a visible-light camera, detects elevated body temperature and signs of fatigue. A successful presentation at the SEECAT 2020 exhibition may lead to possible commercialization of Foresight’s solution in various governmental premises and critical facilities.

 

“We are excited to exhibit, for the first time, the first generation of our COVID-19 screening solution. The leading Japanese trading house requested that we exhibit our screening solution at SEECAT 2020 Japan, a technology exhibition targeting potential clients from the public safety and defense sector, as well as those representing key energy services and large commercial facilities. As the COVID-19 pandemic crisis remains a matter of international importance, it is of great concern to find a solution that will help to detect early symptoms and allow the world to safely return to events and services with large population flows,” said Haim Siboni, CEO of Foresight.

 

About Foresight

 

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” cellular-based applications. Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients’ movement.

 

 

 

 

 

The company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.

 

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, please visit www.foresightauto.com, follow @ForesightAuto on Twitter, or join Foresight Automotive on LinkedIn, the contents of which are not incorporated into this press release.

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses presenting its COVID-19 symptom detection mass screening solution at SEECAT 2020 and that a successful presentation at the SEECAT 2020 exhibition may lead to possible commercialization of the solution. Because such statements deal with future events and are based on Foresight’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release.

 

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Foresight's annual report on Form 20-F filed with the Securities and Exchange Commission ("SEC") on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third-party websites. 

 

Investor Relations Contact:

 

Miri Segal-Scharia
CEO
MS-IR LLC
msegal@ms-ir.com
917-607-8654